ArticleFrontiers in microbiology2023

Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents.

Shopnil Akash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.